Galera Therapeutics
develops and commercializes novel mechanism-based therapies for the treatment of cancer... Read moreGalera Therapeutics
develops and commercializes novel mechanism-based therapies for the treatment of cancer... Read more
News
May 14, 2026
Benzinga
Galera Therapeutics: Galera Therapeutics Q1 EPS $(0.01), Same YoY
Apr 15, 2026
RTTNews
Galera Therapeutics: Galera Therapeutics, Obsidian Therapeutics Announces All-Stock Merger; Stock Up
Apr 15, 2026
BioPharma Dive
Galera Therapeutics: Obsidian, Galera to advance cell therapy following reverse merger
Apr 14, 2026
GlobalNewswire
Press Release: Galera Therapeutics : $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Galera Therapeutics, Inc. (OTCMKTS: GRTX)
Mar 20, 2026
Owler
Galera Therapeutics, Inc.: Galera Therapeutics's employee count had no change from Dec 2024 to Dec 2025
Mar 19, 2026
Marketscreener
Galera Therapeutics: Galera Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
Nov 13, 2025
Benzinga
Galera Therapeutics: Galera Therapeutics Q3 EPS $(0.01) Up From $(...
Oct 22, 2025
Citybizlist
Galera Therapeutics: Galera Therapeutics Acquires Dismutase Mimetics Portfolio by Biossil For $105 Million
Apr 01, 2025
Owler
Galera Therapeutics, Inc.: Galera Therapeutics's employee count changed from 7 in Mar 2024 to 3 in Dec 2024
Jan 14, 2025
SEC
Galera Therapeutics: Galera Therapeutics, Inc. has raised $2,738,355 in Funding
